Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

The update reports the completion of Phase 1 and Phase 2 studies evaluating the safety, pharmacokinetics, and efficacy of AK120 in subjects with atopic dermatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK120

Snippet

Sponsor: Akeso | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED